Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
1,10‑Phenanthroline is a synthetic heterocyclic organic compound with the formula C₁₂H₈N₂. It is a white to light yellow crystalline powder at room temperature and is moderately soluble in water and various organic solvents[3][6]. The molecule features two nitrogen atoms at the 1 and 10 positions of a three-ringed aromatic system. It acts as a bidentate ligand in coordination chemistry, forming stable colored complexes with many metal ions—most notably iron(II), where it forms the red complex ferroin[2][5]. In biochemistry and pharmacology research, it serves as an inhibitor of metallopeptidases (notably carboxypeptidase A) by chelating essential metal ions such as zinc from enzyme active sites[1][8]. It also inhibits deubiquitination enzymes like Rpn11[2], displays antimicrobial activity[3][5], can prevent chromosomal aberrations induced by certain chemicals[6], and has been studied for potential anticancer properties through its DNA cleavage activity when complexed with metals[7]. While widely used as an analytical reagent for metal ion detection and quantification due to its colorimetric properties, it is not approved or marketed as a pharmaceutical drug for any disease indication in humans[4].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on 1,10-phenanthroline.